日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

AstraZeneca to build $200m center in China

Updated: 2011-10-12 09:56

By Ma Zhenhuan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

AstraZeneca to build $200m center in China

AstraZeneca PLC workers load blister strips onto a packing line at a factory in Macclesfield, United Kingdom. The UK-based medical company will create 600 jobs by building a new factory in Taizhou, Jiangsu province. [Photo / Bloomberg]

SHANGHAI - AstraZeneca PLC, one of the world's leading pharmaceutical companies, said it would invest $200 million to launch a new manufacturing facility in China to meet growing demand, including in rural areas.

Construction work on the project, in the China Medical City in Taizhou of East China's Jiangsu province, is scheduled for completion by the end of 2013, creating approximately 600 jobs.

This will be London-based AstraZeneca's largest single investment in a manufacturing facility globally. The new plant will produce intravenous and oral solid products, the company said.

"The new facility will significantly enhance our capacity and allow us to meet the growing healthcare demand of the Chinese population, and help us expand into the 900 million (rural) people outside of the big cities and hospitals," Mark Mallon, president of AstraZeneca China, told China Daily in an exclusive interview on Monday.

"It will also allow us to free up some capacity at our existing manufacturing facility in Wuxi, Jiangsu, to bring on more new innovative products that will be launched over the next few years," he added.

The Chinese pharmaceutical market grew from $10 billion in 2004 to $41 billion in 2010, according to market research agency IMS Health Inc, and it is expected to reach $102 billion by 2015.

Mallon said that he believes the Chinese government's focus on healthcare reform and investment in improving healthcare infrastructure and expanding insurance coverage will continue to drive the company's business growth and increase access to quality medicines over the longer term.

AstraZeneca will launch two new products, Faslodex, a treatment for breast cancer, and Onglyza, a new treatment for Type-2 Diabetes, in China this year.

Mallon also mentioned that the company is planning to launch Brilinta, an oral antiplatelet treatment for acute coronary syndrome, next year in China.

With an enhanced manufacturing capacity and the launch of more innovative new medicines, the company is planning to produce more affordable medicines for Chinese patients. It will adopt a multi-channel approach to sell its products to markets beyond big cities and hospitals.

Aside from the medical sales representatives who deal with individual physicians in big cities, the company has developed a team of about 100 customer service representatives who organize educational programs for small clinics and community health centers in China's rural areas.

It will also set up an inbound and outbound call center to reach out to healthcare professionals through phone calls, helping them learn more about AstraZeneca products, he said.

The company, which entered China in 1993, has invested about $500 million in the country, including an innovation center in Zhangjiang, Shanghai.

主站蜘蛛池模板: 国产五十路 | 久久影院一区 | 国产美女高潮 | 夜夜操天天干 | 亚洲国产91 | 国产97免费视频 | 国产成人午夜 | 色444| 国产xxx视频| 亚洲成人激情视频 | 久久精品国产一区二区三区 | 国产成人三级在线观看 | 欧美日韩系列 | 精品久久国产视频 | 欧美日韩在线视频免费播放 | 国产日韩成人 | 日韩成人高清 | 国产不卡在线观看 | 蜜臀久久99精品久久久画质超高清 | 午夜在线视频 | 激情综合婷婷 | 婷婷网址 | 香蕉视频在线免费播放 | 性爱一级视频 | 亚洲第一网站 | 国产一级色片 | 四虎影院网站 | 国产无遮挡免费视频 | 哪有黄色网址 | 波多野结衣一区二区三区高清 | 波多野结衣在线观看一区二区三区 | 国产97在线视频 | 欧美精品成人 | 伊人影院在线观看 | 国产精品88av| 日本黄色高清视频 | 天堂网在线资源 | 美女特级毛片 | 日韩免费观看一区二区 | 日韩中文字幕久久 | a亚洲天堂 |